Frequency of microalbuminuria and its relationship with other atherosclerotic risk factors in nondiabetic hypertensive patients [16]

Anadolu Kardiyoloji Dergisi

Volumn 7, Issue 2, 2007, Pages 224-226

  Özkurt, Zübeyde Nur ^a   Ebinç, Fatma Ayerden ^a   Keleş, Hatice ^a   Ebinç, Haksun ^a,b   Güliter, Sefa ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CHI SQUARE TEST; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FREQUENCY ANALYSIS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LETTER; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; OBESITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGE FACTORS; ALBUMINURIA; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICAL RECORDS; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TURKEY;

EID: 34250024623     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Pontremoli R., Leoncini G, Viazzi F, Parodi D, Ratto E, Vettoretti S, et al. Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension. J Am Soc Nephrol 2004; 15 (Supp II): S34-6.
2. Rosa TT, Palatini P. Clinical value of microalbuminuria in hypertension. J Hypertens 2000; 18: 645-54.
3. Volpe M, Cosentino F, Ruilope LM. Is it time to measure microalbuminuria in hypertension? J Hypertens 2003; 21: 1213-20.
4. Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens 2003; 16: 952-8.
5. Segura J, Campo C, Roldan C, Christiansen H, Vigil L, Garcia-Robles R, et al. Hypertensive renal damage in metabolic syndrome is associated with glucose metabolism disturbances. J Am Soc Nephrol 2004; 15 (Suppl 1): S37-42.
6. Grandi AM, Santillo R, Bertolini A, Imperiale D, Broggi R, Colombo S, et al. Microalbuminuria as a marker of preclinical diastolic dysfunction in never-treated essential hypertensives. Am J Hypertens 2001; 14: 644-8.
7. Mule G, Cottone S, Vadalá A, Volpe V, Mezzatesta G, Mongiovi R, et al. Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients. J Intern Med 2004; 256: 22-9.
8. Verhave JC, Hillege HL, Burgerhof JGM, Navis G, de Zeeuw D, de Jong PE; PREVEND Study Group. Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. J Am Soc Nephrol 2003; 14: 1330-5.
9. Toft I, Bønaa KH, Eikrem J, Bendiksen AL, Iversen H, Jenssen T. Microalbuminuria in hypertension is not a determinant of insulin resistance. Kidney Int 2002; 61: 1445-52.
10. Vazquez Vigoa A, Vazquez Cruz A, Calderin RO, Buchaca EF, Cruz Alvarez NM, Jimenez Paneque R, et al. Metabolic syndrome in patients with essential hypertension. Nefrologia 2003; 23: 423-31.